top of page
Buscar

Why Chronic Pain Persists, and Where Shockwave Therapy Acts

Foto do escritor: Cecilia Baldoni, PhD
Cecilia Baldoni, PhD
há 23 horas
3 min de leitura

In chronic musculoskeletal pain, the symptom often outlasts the healing of the tissue that caused it. The nervous system keeps amplifying the signal, which is why a treatment aimed at a single target so often gives only partial relief.

MTS Medical’s new whitepaper, Mechanisms of Focused Shockwave Therapy in Chronic Pain, proposes that four interlocking biological drivers sustain that amplification, each feeding the others. The same four drivers offer a way to understand how shockwave therapy for chronic pain works, because its biological effects map onto them. The whitepaper traces the molecular pathways and reviews the evidence study by study.

Extracorporeal shock wave therapy (ESWT) appears to relieve chronic musculoskeletal pain by acting on several of its drivers at once rather than on a single target. Preclinical research shows effects on blood vessel growth, on inflammation, and on the nerve fibres that carry pain signals. Clinically, a 2024 meta-analysis of 45 randomised trials found significant pain reduction in plantar fasciitis, lateral epicondylitis, and Achilles and rotator cuff tendinopathy.


Why chronic pain sustains itself

Pain starts at nociceptors, the nerve endings in skin, muscle, tendon, joint capsule and fascia that respond to stimuli intense enough to signal damage. When tissue is injured or repeatedly overloaded, chemical mediators lower their threshold, and stimuli that would normally be harmless begin to hurt. This is peripheral sensitisation. Immune cells recruited to the site keep it going by releasing signalling proteins (cytokines) that sensitise the nerve endings further.

Persistent input then changes the spinal cord itself. Pain-relaying neurons become hyperexcitable, their synapses strengthen and the neurons that normally dampen the signal weaken, a process called central sensitisation. It produces pain that spreads beyond the original site and outlasts tissue healing. In most chronic musculoskeletal pain, though, input from the affected tissue still feeds that amplification, which leaves room for a treatment that works at the periphery.

Line diagram of the ascending pain pathway: a dashed line runs from a nociceptor in the fingertip through the dorsal root ganglion and spinal dorsal horn, then up the brain stem to the thalamus and cerebral cortex.

Four loops keep this sensitisation going, and sensitisation feeds each of them in return:


  • Vascular. Poor blood supply leaves tissue short of oxygen (ischaemia), which sensitises nerve endings, and the inflammation those nerves release raises tissue pressure and worsens blood flow further.

  • Inflammatory. Persistent inflammatory signalling sensitises nociceptors, which draws in more immune cells and sustains the signalling.

  • Structural. Disorganised collagen leaves tissue mechanically weak, so normal loading causes reinjury and reactivates nociceptors.

  • Neural. Activated immune cells in the spinal cord (microglia) drive central sensitisation, which amplifies incoming signals and keeps the microglia active.

Because each loop sustains the others, interrupting one leaves the rest intact. The whitepaper follows each loop down to its molecular pathway.


Where shockwave therapy for chronic pain acts

A shockwave is a mechanical stimulus, and cells respond to it through mechanotransduction, converting physical force into biochemical signals. In preclinical research, the pressure pulse briefly opened cell membranes and released RNA. That RNA activated an immune receptor, Toll-like receptor 3 (TLR3), which switched on new blood vessel growth. Without TLR3, the effect disappeared.

That pathway reaches the vascular loop. As with any preclinical research, the result is a mechanism-level signal, and human tissue involves additional complexity not captured here. The whitepaper traces the chain through the other loops, from collagen remodelling and tendon integrity in the structural loop to how quickly treatment depletes pain mediators.


Why relief can outlast the treatment

If chronic pain is a self-sustaining cycle, easing several drivers at once could push it below the level it needs to keep going, and the lower-pain state would then persist after treatment ends. Durable relief would not require the shockwave to reach the spinal cord, because reducing the peripheral input that feeds central sensitisation may be enough.

The clinical pattern fits this model. A 2024 meta-analysis of six randomised trials (276 patients) in chronic lateral epicondylitis compared ESWT with corticosteroid injection. Corticosteroid injection led at one month. By three and six months, ESWT had overtaken it on pain, grip strength and function, with mild and comparable adverse events. The whitepaper reviews this evidence study by study.



Chronic musculoskeletal pain persists because its vascular, inflammatory, structural and neural drivers keep one another going, and a single mechanical stimulus that reaches several of them offers a biologically coherent way to break the cycle. The whitepaper follows the shockwave from the first pressure pulse to the pain signal and sets out the clinical evidence behind it.


Download the whitepaper for the full mechanism and evidence review.



Disclaimer

This content is intended for qualified healthcare professionals and is provided for informational and educational purposes only. It does not constitute medical advice. Clinical decisions must be made by a qualified healthcare professional based on the individual patient's circumstances.


 
 

Terapia

Dermatologia
Ortopedia
Urologia

Evidências
Tecnologia
Soluções Spark Wave

Notícias

Sobre nós

MySpark

Feeds sociais
Últimos eventos

História
Rede global
Carreira

Portal do Cliente

Contacto

T   +49 (0)7531 36185-0

E    info@mts-medical.com

      Agendar consulta

​

© MTS Medical AG 2026. Todos os direitos reservados.

Este site e o seu conteúdo estão protegidos por direitos autorais e outras leis de propriedade intelectual.

  • MTS Medical LinkedIn
  • MTS Medical Facebook
  • MTS Medical Instagram
  • MTS Medical Youtube

Como ajudamos

​IMPRESSÃO  /  TERMOS E PRIVACIDADE

bottom of page